Triveni Bio
Healthcare & Life Sciences
Recent Finacing
Series B
Recent Raise
$115M
Triveni Bio is a biotech company developing novel antibody treatments for immunological and inflammatory disorders.
Focus Areas
biotech
antibody treatments
immunological disorders
inflammatory disorders
bispecific program
data science platform
Investors